NasdaqGS - Nasdaq Real Time Price USD
Vor Biopharma Inc. (VOR)
0.6969
+0.0105
+(1.53%)
As of 3:49:37 PM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 56,166,260 | 6 |
| Sales | 15,115 | 3 |
| Net Shares Purchased (Sold) | 56,151,145 | 9 |
| Total Insider Shares Held | 39.97M | -- |
| % Net Shares Purchased (Sold) | -347.00% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| ATTAR EYAL C Officer | Sale at price 1.42 per share. | Direct | 3,162 | Feb 13, 2025 |
| ATTAR EYAL C Officer | Sale at price 1.37 per share. | Direct | 3,499 | Feb 10, 2025 |
| ANG ROBERT M.D. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 3, 2025 |
| ATTAR EYAL C Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 3, 2025 |
| CHAKRABORTY TIRTHA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 3, 2025 |
| CHOI HAN WOOK Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 3, 2025 |
| RA CAPITAL MANAGEMENT, L.P. Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 0.00 per share. | Indirect | 0 | Dec 30, 2024 |
| REPROGRAMMED INTERCHANGE LLC Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.19 per share. | Indirect | 46,379,180 | Dec 30, 2024 |
| ATTAR EYAL C Officer | Sale at price 1.25 per share. | Direct | 12,918 | Dec 27, 2024 |
| ATTAR EYAL C Officer | Sale at price 1.39 per share. | Direct | 20,357 | Jun 3, 2024 |
| ANG ROBERT M.D. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 29, 2024 |
| ATTAR EYAL C Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 29, 2024 |
| CHAKRABORTY TIRTHA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 29, 2024 |
| JORGENSEN NATHAN D. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 29, 2024 |
Related Tickers
BCAB BioAtla, Inc.
0.3555
+4.90%
ALEC Alector, Inc.
1.1050
+13.52%
CGEM Cullinan Therapeutics, Inc.
8.36
+3.21%
IPSC Century Therapeutics, Inc.
0.5301
-1.83%
NKTX Nkarta, Inc.
2.2350
+20.75%
IMCR Immunocore Holdings plc
29.51
+0.34%
ANAB AnaptysBio, Inc.
21.62
+4.85%
ELEV Elevation Oncology, Inc.
0.3697
-2.22%
PASG Passage Bio, Inc.
0.3431
-4.06%
PMVP PMV Pharmaceuticals, Inc.
1.0950
-0.46%